InvestorsHub Logo

PlentyParanoid

01/04/19 4:55 PM

#253440 RE: scottsmith #252566

Maybe you should read this Protagonist PR and then decide what to do with this post.

https://www.prnewswire.com/news-releases/final-results-from-the-protagonist-propel-study-support-further-clinical-development-of-ptg-100-for-the-treatment-of-ulcerative-colitis-300692199.html

looks like Protagonist ended up wasting 200 subject study on ulcerative colitis on CRO error and now probably needs to re-do it. Savings for stockholders? Oh man!